Navigation Links
Lexicon Initiates Phase 2 Clinical Trial of LX2931 in Patients With Rheumatoid Arthritis
Date:8/4/2009

y from irreversible joint damage. According to the National Institutes of Health, autoimmune disorders affect between 14.7 and 23.5 million people in the United States.

About Lexicon

Lexicon is a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease. Lexicon currently has five drug candidates in development for autoimmune disease, carcinoid syndrome, diabetes, glaucoma and irritable bowel syndrome, all of which were discovered by the company's research team. The company has used its proprietary gene knockout technology to identify more than 100 promising drug targets. Lexicon has focused drug discovery efforts on these biologically-validated targets to create its extensive pipeline of clinical and preclinical programs. For additional information about Lexicon and its programs, please visit www.lexpharma.com.

Safe Harbor Statement

This press release contains "forward-looking statements," including statements relating to Lexicon's clinical development of LX2931 and the potential therapeutic and commercial potential of LX2931. This press release also contains forward-looking statements relating to Lexicon's growth and future operating results, discovery and development of products, strategic alliances and intellectual property, as well as other matters that are not historical facts or information. All forward-looking statements are based on management's current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including those relating to Lexicon's ability to successfully conduct clinical development of LX2931 and preclinical and clinical development of its other potential drug candidates, advance additional candidates into preclinical and clinical development, obtain necessary regulato
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results
2. Tyco International Increases Quarterly Dividend 36 Percent to 15 Cents per Share; Initiates New $1 Billion Share Repurchase Program
3. Chemical Diversity Initiates International Prostrate Cancer Discovery Partnership
4. Vista Partners Initiates Coverage on Raptor Pharmaceuticals Corp.
5. GenPrime Initiates External Clinical Trials of its Bacterial Contamination Test for Rapid Detection of Bacteria in Platelets
6. U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors
7. Harbinger Research Initiates Coverage on HearAtLast
8. Wyeth Consumer Healthcare Initiates Voluntary Recall and Replacement Program for Several Robitussin Products and Childrens Dimetapp Cold & Chest Congestion
9. MAP Pharmaceuticals Initiates Phase 2a Clinical Trial of Combination Therapy in Adult Patients with Asthma
10. Amira Pharmaceuticals Announces Favorable Phase 1 Clinical Trial Results for Lead Product Candidate AM103 and Initiates Clinical Studies for the 2nd Entry Molecule for the Treatment of Respiratory and Cardiovascular Disease
11. Arete Therapeutics Initiates Phase 1 Clinical Trial For AR9281 as a First-in-Class Antihypertensive Agent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... IL (PRWEB) June 19, 2013 Chicago is ... the 31st, 48th and 50th Chicago Wards will require landlords ... – or face fines. The ordinance also makes ... complying with all treatment requests – which often include disposing ... pest control company Orkin reported that it did more bed ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 The Cancer ... the promise of cancer care for the whole patient ... at the Cancer Support Community. This inaugural event, held ... Ezekiel Emanuel, MD., Ph.D., recognition of Congress members who ... the voices of patients and families currently engaged in ...
(Date:6/19/2013)... Chicago, IL (PRWEB) June 19, 2013 ... patients, but for those closest to them. The sudden ... effects a brain tumor has on a patient’s behavioral ... uncertainty for both the patient and family. The ... , Friday, July 26 and Saturday, July 27 in ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Arem Wellness ... thyroid and metabolism expert, Dr. Ridha Arem, who is ... To help achieve this goal, Arem Wellness provides a ... and the mind-body program as well as an exceptional ... Dr. Arem understands the crucial role diet and nutrition ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 GoTunes Inc. ... a free music and fitness app for creating and ... discover new Spotify songs that match your exercise pace, ... exercise, and add songs to your favorite playlists. You ... curated by the GoTunes staff. , Get the free ...
Breaking Medicine News(10 mins):Health News:Chicago Ordinance Requires Landlords and Tenants to Take Responsibility for Bed Bugs 2Health News:Keeping the Promise of Cancer Care for the Whole Patient 2Health News:Keeping the Promise of Cancer Care for the Whole Patient 3Health News:American Brain Tumor Association Conference Advances Holistic Approach to Living with a Brain Tumor 2Health News:American Brain Tumor Association Conference Advances Holistic Approach to Living with a Brain Tumor 3Health News:Arem Wellness Announces a Recipe Contest 2Health News:Arem Wellness Announces a Recipe Contest 3Health News:The GoTunes Iphone App Creates a Streaming Workout Music Community Via Spotify 2
... Texas, Aug. 12 American,HealthChoice, Inc. (Pink Sheets: ... clinics in Texas and Tennessee, is pleased to ... Scan, an infrared thermal imaging camera,that will be ... human body.,In conjunction with existing technologies, the OmniBody ...
... by attending a free webinar hosted by USA-ONE interactive - the ... management professional, is a rare opportunity to see a hands-on approach ... ... Denver, CO (PRWEB) August 12, 2008 – http://www.usa-one.com/ ...
... A world-renowned panel of 130 cardiologists and scientists, ... of Cardiology (IAC) announced the 2008 International Academy ... the 14th World Congress on Heart Disease held ... Harisios Boudoulas, M.D.; Professor Robert Roberts, M.D.; Professor ...
... People who lose weight soon after a diagnosis ... pressure and blood sugar, and are more likely to maintain ... a Kaiser Permanente study published online in Diabetes Care ... is the first clinical study to show that benefits remain ...
... MEDRAD, INC., announced today,that the wireless version ... Food and Drug Administration (FDA) 510(k) clearance., ... Continuum Wireless MR Infusion System enables the clinician ... resonance (MR),procedure from both inside and outside the ...
... Aug. 11 Celsius Holdings,Inc. (OTC Bulletin Board: CSUH.OB) reported ... 2008 of $1.0 million -- a substantial increase,as compared to ... company also reported a net loss of $916,000 (or $0.01 ... 30, 2007. This compares,with net loss of $726,000 (or $0.01 ...
Cached Medicine News:Health News:American HealthChoice Announces Launch of OmniBody Scan 2Health News:American HealthChoice Announces Launch of OmniBody Scan 3Health News:USA-ONE Interactive Presents a Free Webinar Series Introducing Docuvation – An Online Document Management Solution 2Health News:Distinguished Cardiologists and Scientists Honored With 2008 International Academy of Cardiology Award 2Health News:Distinguished Cardiologists and Scientists Honored With 2008 International Academy of Cardiology Award 3Health News:Distinguished Cardiologists and Scientists Honored With 2008 International Academy of Cardiology Award 4Health News:Distinguished Cardiologists and Scientists Honored With 2008 International Academy of Cardiology Award 5Health News:Distinguished Cardiologists and Scientists Honored With 2008 International Academy of Cardiology Award 6Health News:Losing weight soon after type 2 diabetes diagnosis doubles positive outcomes 2Health News:MEDRAD Receives FDA 510(k) Clearance for Wireless MR Infusion System 2Health News:MEDRAD Receives FDA 510(k) Clearance for Wireless MR Infusion System 3Health News:Celsius Holdings Reports Increased Revenue 2nd Quarter Revenue Increased 166% 2Health News:Celsius Holdings Reports Increased Revenue 2nd Quarter Revenue Increased 166% 3Health News:Celsius Holdings Reports Increased Revenue 2nd Quarter Revenue Increased 166% 4Health News:Celsius Holdings Reports Increased Revenue 2nd Quarter Revenue Increased 166% 5
(Date:6/18/2013)... -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... public offering of common shares (the "Offering"). Pursuant to ... at a price of $85.00 per share, for aggregate ... file a final prospectus supplement to its effective shelf ... similar filing with the securities regulatory authorities in each ...
(Date:6/18/2013)... 2013  Recent regulatory and budget challenges have made ... at large pharmaceutical companies to effectively educate doctors and ... of their new products. With the pressure to reduce ... that these "Med Ed" groups find practical, ... address the changes that are transforming the Medical Education ...
(Date:6/18/2013)... Calif. , June 18, 2013  Women are ... families, but unfortunately they often do not give the ... women have kept information from their doctor because they ... it, according to a recent survey conducted by Allergan ... organization dedicated to bringing education, funding and research to ...
Breaking Medicine Technology:Valeant Pharmaceuticals Prices Public Offering Of Common Shares 2Valeant Pharmaceuticals Prices Public Offering Of Common Shares 3Valeant Pharmaceuticals Prices Public Offering Of Common Shares 4Though Vital to Educating Doctors on New Products, Pharma "Med Ed" Groups Working Under Huge Internal & External Constraints 2New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 2New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 3New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 4New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 5New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 6New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 7New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 8New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 9
... YORK, November 22, 2011 According to a new ... Global Drug Eluting (DES), Bare Metal (BMS) and Other ... Stents market is estimated to be USD 6,013million in 2011 and ... 6.6% over the period 2010 to 2016. The Drug Eluting Stents ...
... 2011 The Female Health Company (FHCO- NASDAQ-CM) today announced ... (RSA), Sekunjalo Investments Corporation (PTY) Ltd., has received an order ... million FC2 Female Condoms for delivery as soon as possible. ... O.B. Parrish, Chairman and C.E.O. of The ...
Cached Medicine Technology:The Global Drug Eluting & Bare Metal Coronary Stents Market is Booming: Expected to Attain a Market Size of USD 8.3 Billion by 2016 2The Global Drug Eluting & Bare Metal Coronary Stents Market is Booming: Expected to Attain a Market Size of USD 8.3 Billion by 2016 3The Global Drug Eluting & Bare Metal Coronary Stents Market is Booming: Expected to Attain a Market Size of USD 8.3 Billion by 2016 4The Global Drug Eluting & Bare Metal Coronary Stents Market is Booming: Expected to Attain a Market Size of USD 8.3 Billion by 2016 5The Female Health Company's Distributor, Sekunjalo Investments Corporation (PTY) Ltd., Receives Order for 5 Million FC2 Female Condoms From the Republic of South Africa Department of Health 2The Female Health Company's Distributor, Sekunjalo Investments Corporation (PTY) Ltd., Receives Order for 5 Million FC2 Female Condoms From the Republic of South Africa Department of Health 3
... USA 2001 Universal Battery Charger is manufactured to ... Versipower Plus and 3M MaxiDriver II Battery Packs. ... six Battery Packs simultaneously in less than 40 ... on 120 volt AC grounded electrical power. If ...
... The Brasseler USA™ Battery Packs contain ... age have a great impact upon battery ... is necessary. Any deviation from these recommendations ... are sensitive to heat. Any exposure of ...
The High Speed Drill handpiece is a well-balanced, high performance drill that provides high speed for,bone sculpting, along with power for difficult osteotomies. Must be used with the 6401-000 foot ...
... Module, with hand throttle. Accepts all 1000 ... 10ft. air hose 9000-000, or existing hose ... hose 9013-000, or existing hose with Linvatec/Hall ... or existing hose with 3M connector (1000-300). ...
Medicine Products: